Alcyone Lifesciences logo

Alcyone Lifesciences

Empowering Precision Therapies for Rare Neurological Disorders

est. 2010

VS
뉴로핏 (Neurophet) logo

뉴로핏 (Neurophet)

Global pioneer to lead diagnosis and treatment of brain disorders, Neurophet —— 뇌질환 진단과 치료를 선도하는 글로벌 리딩 컴퍼니, 뉴로핏

65 employees · est. 2016 · Seoul, Korea South

Alcyone Lifesciences is the older company (2010 vs 2016).

Side-by-Side Comparison

Alcyone Lifesciences 뉴로핏 (Neurophet)
Founded
2010 older 2016
Headquarters
Not tracked yet Seoul, Korea South
Employees
Not tracked yet 65
Industry
Biotechnology, Health Care AI, Machine Learning
Funding Stage
Series Unknown Series C
Total Funding
$15.58M $48.00B
Funding Rounds
5 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Neurological Disorders, Molecular Therapy, Precision Delivery, Brain-targeted Therapy, Blood-brain Barrier, Drug Delivery Technology, Rare Diseases, Orphan Disorders, Precision Medicine, CNS Therapy, Advanced Therapy Platforms, Neuropathological Conditions, Disease-modifying Therapy Neuroscience, Neuroimaging, Medical Imaging, Neuroradiology, MRI, PET, Brain Disorders, Artificial Intelligence, Brain Health, Brain MRI Imaging, PET Scan Analysis, Stimulation Simulation, Neuro-navigation System
Website
alcyonels.com neurophet.com
Alcyone Lifesciences logo

About Alcyone Lifesciences

Alcyone Lifesciences is a biotechnology startup with a focus on developing precision therapies for rare neurological disorders. Founded in 2010, the company's mission is to address critical gaps in the treatment of chronic neuropathological conditions by enhancing molecular therapy for the brain. Al...

뉴로핏 (Neurophet) logo

About 뉴로핏 (Neurophet)

Neurophet is a South Korean startup, founded in 2016, focused on harnessing cutting-edge artificial intelligence (AI) technology to develop solutions for brain disorders. Led by CEO Jake Junkil Been and CTO Donghyeon Kim, the company's flagship products include the brain MRI imaging analysis softwar...

We will tell you when either one moves

BounceWatch watches Alcyone Lifesciences and 뉴로핏 (Neurophet) for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Alcyone Lifesciences and 뉴로핏 (Neurophet) — by email.

Frequently Asked Questions

Alcyone Lifesciences — Empowering Precision Therapies for Rare Neurological Disorders. 뉴로핏 (Neurophet) — Global pioneer to lead diagnosis and treatment of brain disorders, Neurophet —— 뇌질환 진단과 치료를 선도하는 글로벌 리딩 컴퍼니, 뉴로핏. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Alcyone Lifesciences has raised $15.58M while 뉴로핏 (Neurophet) has raised $48.00B.
Alcyone Lifesciences and 뉴로핏 (Neurophet) operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Alcyone Lifesciences with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Alcyone Lifesciences on 12 Sep 2024, and 뉴로핏 (Neurophet) on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes